Hefei Hengxin Life Technology Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or major omissions.
I. Basic Situation of Fundraising
According to the approval from the China Securities Regulatory Commission regarding the registration of the Company's initial public offering (Approval No. [2024] 1909), the Company issued 25,500,000 ordinary shares of RMB 1.00 each at an issue price of RMB 39.92 per share, raising a total of RMB 1,017,960,000. After deducting issuance expenses (excluding VAT) of RMB 119,045,300, the actual net fundraising amount is RMB 898,914,700. The aforementioned fundraising has been transferred to the Company's designated account on March 13, 2025. Rongcheng Accounting Firm (Special General Partnership) has verified the arrival of the fundraising and issued the verification report "Rongcheng Verification No. [2025] 230Z0024." The fundraising has been deposited in a special account established by the Company, and the Company has signed a tripartite supervision agreement with the sponsor and the relevant banks to manage the storage and use of the fundraising.